NIH Active Patent Commercialization Licenses
Download a CSV of the complete license data set.
Reset the Search Filters to go back to the initial display of all records.
Questions? See the NIH Active Patent Commercialization Licenses FAQ.
| ID | Lead IC | Licensee | Territory | Exclusivity | Fiscal Year | Execution Date | Effective Date | Technology ID |
|---|---|---|---|---|---|---|---|---|
| L-303-2019 | NIAID | TaiMed Biologics USA, Inc | Worldwide | Nonexclusive | 2021 | E-051-2012 | ||
| L-222-2020 | NCI | Senti Biosciences, Inc. | Worldwide | Exclusive | 2021 | E-133-2016 | ||
| L-099-2020 | NCI | Kite Pharma, Inc.(Gilead Sciences, Inc.) | Worldwide | Exclusive | 2021 | E-282-2016 E-150-2017 |
||
| L-159-2021 | NCI | Kyverna Therapeutics, Inc. | Worldwide | Exclusive | 2021 | E-042-2014 | ||
| L-221-2016 | NIAID | Sanofi Pasteur (AVP) | Worldwide | Exclusive | 2021 | E-194-1999 E-135-2010 E-216-2014 E-241-2014 E-037-2016 E-042-2018 E-143-2018 |
||
| L-158-2021 | NCI | Kyverna Therapeutics, Inc. | Worldwide | Exclusive | 2021 | E-042-2014 | ||
| L-156-2021 | NCI | Senti Biosciences, Inc. | Worldwide | Exclusive | 2021 | E-097-2018 | ||
| L-059-2021 | NIAID | BioMerieux S. A. | Worldwide | Nonexclusive | 2021 | E-004-2009 | ||
| L-050-2011 | NINDS | Passy-Muir, Inc. | Worldwide | Exclusive | 2021 | E-251-2005 | ||
| L-197-2005 | NIAID | Serum Institute of India PVT. LTD. | Foreign | Nonexclusive | 2021 | E-015-1998 | ||
| L-048-2015 | NCI | PDS Biotechnology Corporation | Worldwide | Nonexclusive | 2021 | E-321-2003 E-001-2012 E-520-2013 |
||
| L-073-2021 | NCI | AevisBio, Inc. | Worldwide | Exclusive | 2021 | E-045-2012 E-208-2015 |
||
| L-050-2021 | NEI | CellRay, LLC | Worldwide | Exclusive | 2021 | E-251-2012 E-192-2014 E-212-2015 E-094-2016 E-293-2016 E-058-2018 E-015-2019 |
||
| L-033-2021 | NIAID | ACROBiosystems Inc. | Worldwide | Nonexclusive | 2021 | E-234-2016 E-086-2020 |
||
| L-080-2006 | NIAID | Panacea Biotech Ltd. | Other | Nonexclusive | 2021 | E-170-1991 E-120-2001 E-089-2002 E-139-2006 |
||
| L-069-2021 | NCI | Cytovia Therapeutics | Worldwide | Exclusive | 2021 | E-136-2012 E-016-2018 |
||
| L-020-2021 | NEI | FUJIFILM Cellular Dynamics, Inc. | Worldwide | Exclusive | 2021 | E-192-2014 E-212-2015 E-094-2016 E-293-2016 E-058-2018 E-015-2019 E-247-2020 |
||
| L-037-2021 | NHLBI | Spark Therapeutics, Inc. | Worldwide | Exclusive | 2021 | E-241-2010 | ||
| L-146-2018 | NHGRI | Leadiant Biosciences, Inc. | Worldwide | Exclusive | 2021 | E-217-2007 | ||
| L-022-2021 | NIBIB | Molecular Targeting Technologies, Inc | Worldwide | Nonexclusive | 2021 | E-150-2016 | ||
| L-015-2021 | NIAID | ExcellGene SA | Worldwide | Nonexclusive | 2021 | E-234-2016 E-086-2020 |
||
| L-024-2021 | NCI | Vor Biopharma, Inc. | Worldwide | Exclusive | 2021 | E-097-2018 | ||
| L-262-2020 | NIAID | Sanofi Pasteur (AVP) | Worldwide | Nonexclusive | 2021 | E-234-2016 E-086-2020 E-116-2020 |
||
| L-257-2020 | NIAID | GeoVax, Inc. | Worldwide | Nonexclusive | 2021 | E-552-1982 E-248-2006 E-018-2010 E-234-2016 E-086-2020 |
||
| L-258-2020 | NCI | Tocris Bioscience | Worldwide | Nonexclusive | 2020 | E-143-2017 E-046-2019 |